Syndax Pharmaceuticals Inc (SNDX)
19.27
-0.02
(-0.10%)
USD |
NASDAQ |
May 31, 16:00
19.25
-0.02
(-0.10%)
After-Hours: 20:00
Syndax Pharmaceuticals Stock Buybacks (Quarterly)
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -258.09M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | |
| December 31, 2022 | -161.96M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | -19.43M |
| March 31, 2022 | |
| December 31, 2021 | -81.21M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | -5.131M |
| March 31, 2021 | |
| December 31, 2020 | -135.33M |
| September 30, 2020 | 0.033M |
| June 30, 2020 | -107.90M |
| March 31, 2020 | -34.87M |
| December 31, 2019 | -0.001M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.192M |
| March 31, 2019 | -28.40M |
| December 31, 2018 | -6.059M |
| September 30, 2018 | -9.438M |
| Date | Value |
|---|---|
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | -25.55M |
| September 30, 2017 | -0.959M |
| June 30, 2017 | -48.84M |
| March 31, 2017 | |
| December 31, 2016 | 0.029M |
| September 30, 2016 | 0.141M |
| June 30, 2016 | 1.231M |
| March 31, 2016 | -53.55M |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.006M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | -0.006M |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-258.09M
Minimum
Dec 2023
0.192M
Maximum
Jun 2019
-50.23M
Average
-2.566M
Median
Stock Buybacks (Quarterly) Benchmarks
| Geron Corp | -141.00M |
| Verastem Inc | -- |
| Karyopharm Therapeutics Inc | -- |
| Crinetics Pharmaceuticals Inc | -383.22M |
| Arvinas Inc | -- |